Research output per year
Research output per year
Fingerprint
The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.
- 1 Similar Profiles
Network
Dive into details by clicking on the dots.
Research output
-
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L. & 7 others, , 2022, In: Acta Oncologica. 61, 4, p. 409-416 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile1 Citation (Scopus)3 Downloads (Pure) -
Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019
Vesteghem, C., Brøndum, R. F., Mouritzen, M. T., Christensen, H. S., Bøgsted, M., Falkmer, U. G. & Poulsen, L. Ø., 7 Apr 2022, (E-pub ahead of print) In: Clinical Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
Open Access -
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy
Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., Frary, J. M. C. & 5 others, , 28 Sep 2021, In: Cancers. 13, 19, 4846.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Citations (Scopus)8 Downloads (Pure) -
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy
Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., Frary, J. M. C. & 5 others, , 2021.Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review
-
Real word experience with first-line immunotherapy in advanced non-small cell lung cancer patients in a Danish nationwide cohort
Mouritzen, M., Bjoernhart, B., Poehl, M., Ladekarl, M., Vesteghem, C., Boegsted, M., Nielsen, A. W. M., Meldgaard, P., Hansen, K. H., Larsen, J. W. W., Kristiansen, C., Wedervang, K., Bareid-Oestby, A-C., Frank, M. S., Persson, G., Kristensen, E. B., Homann, P. H. & Carus, A., 1 Sep 2020, In: Annals of Oncology. 31, Suppl. 4, p. S858 1 p., 1334P .Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Activities
- 4 Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Lægevidenskabelige Selskaber (LVS) (External organisation)
Mette Thune Mouritzen (Chairperson)
2020Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Dansk Onkologisk Lungecancer Gruppe (DOLG) (External organisation)
Mette Thune Mouritzen (Chairperson)
2018Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Foreningen af Yngre Onkologer (FYO) (External organisation)
Mette Thune Mouritzen (Chairperson)
2013Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
-
Lægeforeningen (External organisation)
Mette Thune Mouritzen (Chairperson)
2010Activity: Memberships › Membership of committees, commissions, boards, councils, associations, organisations, or similar
Press / Media
-
Nationalt studie: Immunterapi har løftet overlevelsen ved fremskreden lungekræft betydeligt
31/10/2021 → 04/11/2021
2 items of Media coverage
Press/Media: Press / Media
-
Førstelinje immunterapi af NSCLC er også effektivt i real-world
19/09/2020 → 22/09/2020
4 items of Media coverage
Press/Media: Press / Media
-
Roskilde-forskere får fondspenge
26/10/2019 → 26/10/2019
11 items of Media coverage
Press/Media: Press / Media